The Flamma Group, a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late-stage ...

The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

Cellular Origins, the Cell and Gene Therapy Catapult, and Resolution Therapeutics have formed a consortium funded by Innovate ...

Grand River Aseptic Manufacturing’s Tyler BeVier on strategic partnerships, cutting-edge capacity, and a patient-first ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

Jazz Pharmaceuticals’ Board of Directors has unanimously selected Renee Gala as President and Chief Executive Officer.

The Phase 3 study evaluating quemliclustat plus chemotherapy as a first-line treatment for metastatic pancreatic cancer is ...

Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, has appointed Linda ...

Ofichem Group has agreed to acquire Avivia B.V., a company specialized in formulation development based in Nijmegen, the ...

“With our new hot melt extrusion technology, Aenova is expanding its range of innovative platforms to provide modern, ...

Aptar CSP Technologies, a leader in active material science, has developed a dual-active material science technology ...